Paris, December 4th, 2024
Ysonut is an international laboratory specializing in the active science of nutrition. A pioneer in micronutrition and dietetics for 30 years, Ysonut offers two standout brands, Inovance (micronutrition / food supplements) and Protéifine (protein diet). Both brands are renowned for the effectiveness of their high-quality formulations.
Founded in Montpellier by Marc Sarazin and based in Barcelona since 1998, the Ysonut Group initially developed in France and Spain, and has expanded internationally since the 2000s with operations spanning Europe (Belgium and Portugal) and Latin America (Argentina, Uruguay and Mexico).
Under the leadership of an experienced management team led by its founder, Ysonut has built on its medical expertise and know-how in formulation and R&D capabilities. Historically, the company relied on physicians to prescribe its products. Since 2010, it has also marketed its range of food supplements through pharmacies, supported by a robust training platform for healthcare professionals. Following a competitive process orchestrated by Eurvad, AREV I acquired a stake, with Marc Sarazin reinvesting and retaining a significant share of the company’s capital.
AREV’s strategy focuses on leveraging Ysonut’s medical heritage and formulation expertise to establish a leading position in the food supplements segment in France and Spain. With patients increasingly seeking natural alternatives to pharmaceuticals particularly for managing chronic conditions—Ysonut is well-positioned to provide cutting-edge micronutrition solutions. With AREV’s support, Ysonut aims to accelerate growth in existing markets, explore new geographies and pursue targeted acquisitions to strengthen its position in the food supplements segment.
Marc Sarazin, Founder and CEO of Ysonut, commented: “I’m proud of how far we’ve come since founding Laboratoire Ysonut, and of our development and internationalization. Ysonut’s 30th anniversary also marks the beginning of an exciting partnership with AREV, who will support us in this new chapter of strong growth for the Group, and with whom we are excited to work with. We are looking forward to building on our strengths in formulation know-how and innovation to reinforce our presence in the pharmaceutical and medical sectors as experts in micronutrition”.
Xavier Geismar and Julien Lammoglia, founders of AREV Partners, added: “We are thrilled to partner with Marc Sarazin and share great ambitions for the Ysonut. We were attracted by Group’s positioning in micronutrition, built on its medical expertise and its internationalization over recent years, which is reflected in the company’s growth and performance. Laboratoire Ysonut offers quality solutions and thus contributes to improving the well-being and quality of life of patients, and this transaction is a perfect illustration of AREV’s strategy of investing in companies with a positive impact on society. We will work with the management team to further strengthen Ysonut’s innovation capabilities and accelerate the development of the Inovance brand in pharmacies in France and Spain. Strategically, we will aim to expand the product portfolio, without losing the Group’s medical DNA and micronutrition expertise.”
